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INTRODUCTION
Overweight and obesity represent a rapidly growing health
threat in both developing and developed countries (1). Pri-
mary care physicians play a central role in the systematic assess-
ment and management of obesity (2-7). Guidelines for the
management of obesity have been developed in several coun-
tries, including Korea (8-10).
Like other Asian countries, Korea has experienced rapid
socioeconomic growth with prominent lifestyle transforma-
tion over the past several decades. The Korean National Nutri-
tion Survey found that the prevalence of obesity (BMI ≥25
kg/m2) increased from 20.5% in 1995 (11) to 26.3% in 1998
(12). Concern about weight and weight loss is particularly
prominent in women, even those of normal weight. Physicians
in Korea have become increasingly involved in the treatment
of obesity since anti-obesity drugs became available.
Studies in Western countries have shown that general prac-
titioners do not have sufficient relevant knowledge and skills
to effectively manage overweight and obesity (5, 13-15). A
previous study conducted in urban area in Korea before intro-
duction of anti-obesity agents reported that primary care phy-
sicians had little concern about obesity management (16).
Although weight problems are increasing in developing coun-
tries, there is little information on the attitudes and practices
of physicians in regard to obesity management in Asian coun-
tries. We therefore investigated the attitudes and practices
of primary care physicians in Korea in regard to the assess-
ment and management of obesity after anti-obesity agents
became available. 
MATERIALS AND METHODS
Study subjects
At year 2000, there were about 10,070 physicians of pri-
mary care clinics registered with the Health Insurance Review
Agency of Korea. Our national probability sample frame was
composed of 2,282 family physicians and 2,415 internists
among 10,070 physicians listed in this database. The list of
family physicians and internists was sorted by registered num-
ber of the clinic. To obtain a systematic sample, the number
of 57 was chosen in a table of random numbers as starting
number, after that, every 5th number was selected on the
list of the sample. Finally, the list of 392 family physicians
and 547 internists were obtained as the roll of study subjects.
This study was conducted from April through August in
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Attitudes and Reported Practice for Obesity Management in Korea
After Introduction of Anti-obesity Agents 
This study aimed to evaluate current clinical assessments and management of obe-
sity in the primary care setting in Korea since anti-obesity agents have become avail-
able. A questionnaire was sent to eligible primary care physicians selected from a
national probability sample in two specialties: family physicians and internists. Of
939 randomly selected physicians, 452 (48.1%) replied. We found that 51.8% of
physicians were aware of the definition of obesity, and 33.8% were aware of the
definition of abdominal obesity proposed by Asia-Pacific guideline. When evaluat-
ing apparently obese patients, 50.0% of respondents measured body mass index
(BMI) and 20.4% measured waist circumference. Fewer than 50% of physicians
measured blood glucose or lipid profiles, both of which are risk factors for obesity.
About 47.3% of physicians prescribed an anti-obesity medication without allowing
sufficient time for nonpharmacologic therapy to take effect, and 68.8% of physicians
prescribed anti-obesity medications to patients that requested them regardless of
obesity status. The majority of respondents did not appropriately evaluate obesity
and its risk factors, and were readily susceptible to prescribing anti-obesity medica-
tions. Our findings suggest that primary care physicians in Korea need additional
education on obesity and its management. 
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Survey procedure
Physicians identified as eligible were sent a letter from the
coordinator explaining the purpose of the survey, and question-
naires were sent to physicians who consented to take part. Each
subject received a cover letter, a copy of the questionnaire, and
a return envelope with postage paid. About four weeks after
the initial mailing, nonrespondents received a reminder letter,
together with a second copy of the questionnaire and a return
envelope. At least three follow-up telephone calls were made
before categorizing a physician as a nonrespondent.
Questionnaires
The questionnaires addressed recent developments in obesity
management and were pilot-tested on 12 residents in family
medicine for scope, length, and clarity. The questionnaires,
which were designed to be completed in less than 10 min,
consisted primarily of closed-ended questions and mutually
exclusive sets of questions. 
Demographic Profile: Questions were included regarding
age, sex, geographic region of practice, type of practice, years
as a primary care physician, and numbers of patients and obese
patients seen per day.
Knowledge regarding definition of obesity and abdominal
obesity: The ‘‘knowledge’’ questions consisted of 3 statements
designed to examine physicians’ perception of the definitions
of obesity (BMI ≥25 kg/m2) and abdominal obesity (>90 cm
in males, >80 cm in females) proposed by the Asia-Pacific
(9) and Korean (10) obesity guidelines. 
Practice of screening for obesity and abdominal obesity:
These questions consisted of 2 statements designed to exam-
ine physicians’ practice of screening for obesity and abdomi-
nal obesity in new patients (8).
Practice of assessing anthropometric measurements and
risk factors in apparently obese patients: These questions con-
sisted of 10 statements designed to examine physicians’ assess-
ment of anthropometric measurements and risk factors in
apparently obese patients. The former included weight, body
mass index (BMI), and waist circumference. The latter includ-
ed family history, smoking status, and measurements of blood
pressure, fasting glucose, total cholesterol, triglycerides, and
HDL-cholesterol (8).
Attitudes and practices for managing obesity: The ‘‘attitude
and practice’’ questions consisted of statements designed to
examine physicians’ attitudes and practices toward the man-
agement of obesity. They included nonpharmacologic man-
agement, attitude towards the effectiveness and safety of anti-
obesity medications, and practice or behavior in prescribing
anti-obesity agents.
Data analysis 
The questionnaires were hand-checked for completeness
and coded before data entry. The data were examined by sim-
ple frequency counts because the primary aim of this study
was to describe attitudes and practices of primary care prac-
titioners. The  2-test for trends was used to identify signifi-
cance of trends according to subgroups based on the age of
the physicians and the geographic area in which they prac-
ticed. All analyses were two-tailed, and a p-value <0.05 was
considered statistically significant. Statistical analysis was
performed using SAS 8.0 software for Windows (SAS insti-
tute Inc. Cary, NC, U.S.A.).
RESULTS
Profile of participants
Of the 939 questionnaires distributed, 452 (48.1%) were
returned complete. There were no notable differences of the
profiles of sex, age, region of practice, and specialty between
the physicians who participated in this study and those who
did not. Table 1 presents a profile of the participating physi-
cians. Approximately half were 40-49 yr of age and practiced
in an urban area. Two hundred and nine (46.2%) were family
physicians and 243 (53.8%) were internists. Almost all were
in solo practice, and over three-quarters saw more than 50
patients per day.
Variables Category
Participants
(n=452)
No. (%)
Non-
participants
(n=487)
No. (%)
Sex Male 403 (89.2) 425 (87.3)
Female 49 (10.8) 62 (12.7)
Age (yr) <40 117 (25.9) 133 (27.3)
40-49 251 (55.5) 276 (56.7)
≥50 84 (18.6) 78 (16.0)
Region of practice Urban 223 (49.3) 217 (44.6)
Middle 173 (38.3) 181 (37.2)
Rural 56 (12.4) 89 (18.2)
Specialty Family medicine 209 (46.2) 212 (43.5)
Internal medicine 243 (53.8) 275 (56.5)
Practice type Solo practice 435 (96.2)
Group practice 17 (3.8)
Years as a primary  <5 189 (41.8)
care physician 6-10 138 (30.5)
≥11 125 (27.7)
Average daily number  <50 105 (23.2)
of patients 51-80 185 (40.9)
≥80 162 (35.8)
Average daily number  <1 98 (21.7)
of obese patients 2-5 198 (43.8)
≥6 156 (34.5)
Urban, large cities; Middle, middle and small cities; Rural, district area.
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Knowledge regarding obesity and obesity screening practice
Participants’ knowledge regarding obesity and obesity sc-
reening practice is presented in Table 2. About half of the
respondents (51.8%) were aware of the correct definition of
obesity, BMI ≥25 kg/m2 according to Asia-Pacific guidelines,
(7) and about one-third each correctly identified abdominal
obesity as waist >90 cm for males and >80 cm for females.
Older physicians and those who practiced in rural areas had
lower rates of correct responses to items related to the defini-
tion of abdominal obesity compared to younger physicians
and those who worked in urban areas. 
Regarding screening for obesity, about 15% of physicians
reported measuring the weight and height of new patients, but
only 1.8% of physicians in rural areas took these measure-
ments. Fewer than 5% of the respondents measured waist cir-
cumference to screen for abdominal obesity in new patients,
and physicians in rural areas seldom screened for abdominal
obesity.
Assessments of anthropometric measurements and risk
factors in apparently obese patients 
The frequency of assessments of anthropometric measure-
ments and of risk factors in apparently obese patients is sum-
marized in Table 3. About half of the participants did not
measure weight and BMI, and about 80% did not measure
waist circumference in obese patients. About 40% of physi-
cians evaluated family history of premature coronary heart
disease, and about 60% evaluated smoking status. About 80%
of the participants measured blood pressure in obese patients,
but only about 40% measured fasting plasma glucose levels.
Approximately half of these physicians each measured total
cholesterol and triglyceride, and about one-third measured
HDL-cholesterol in obese patients. Older physicians and those
practicing in rural areas had lower rates of assessment of these
anthropometric measurements and risk factors.
Attitudes and reported practice for management of obesity
The views of primary care physicians on nonpharmacologic
treatments and anti-obesity agents are presented in Table 4.
About 60% of these physicians reported recommending die-
tary modification and exercise therapy. Approximately one-
third of the physicians regarded anti-obesity medications as
effective, whereas 8% thought these agents caused too many
side effects and 60% regarded these agents as too expensive.
Younger physicians and those practicing in urban areas had
Total
Age (yr)
<40 40-49 ≥50
Region
Urban Middle Rural
Correctly defined obesity 51.8 59.8 48.6 50.0 53.8 48.0 55.4
Correctly defined abdominal obesity of males 32.5 29.9 32.7 35.7 37.2 28.3 26.8*
Correctly defined abdominal obesity of females 35.2 42.7 32.7 32.1* 38.1 33.5 28.6*
Screened weight and height in new patients 15.0 12.0 15.5 17.9 16.6 17.3 1.8*
Screened waist circumference in new patients 4.0 3.4 4.4 3.6 4.5 4.6 0.0
Table 2. Primary care physicians’ knowledge and attitude regarding obesity defined by Asia-Pacific guideline and practice of screen-
ing for obesity (as percentage of participants who responded ‘yes’)
*p<0.05 by 
2-test for trend according to subgroups. Urban, large cities; Middle, middle and small cities; Rural, district area.
Total
Age (yr)
<40 40-49 ≥50
Region
Urban Middle Rural
Anthropometric measurements
Weight 68.1 71.8 68.5 61.9* 71.7 73.4 37.5*
Body mass index 50.0 57.3 50.6 38.1* 52.9 55.5 21.4*
Waist circumference 20.4 21.4 20.7 17.9 22.0 23.1 5.4*
Risk factors
Family history
� 42.7 41.0 44.6 39.3 43.5 49.7 17.9*
Smoking 61.3 68.4 60.2 54.8* 62.8 65.3 42.9*
Blood pressure 82.1 82.9 82.9 78.6 83.4 84.4 69.4*
Fasting glucose 44.0 47.0 45.4 35.7* 43.5 45.7 41.1
Total cholesterol 52.2 49.6 54.6 48.8 53.4 53.4 44.6*
Triglyceride 47.8 46.2 51.0 40.5 48.0 50.9 37.5*
HDL-cholesterol 32.7 33.3 35.1 25.0* 33.2 33.5 28.6
Table 3. Primary care physicians’ practice for assessment of anthropometric measurements and risk factors in apparently obese patients
(as percentage of participants who responded ‘yes’) 
*p<0.05 by 
2-test for trend; 
� Family history of premature coronary heart disease. Urban, large cities; Middle, middle and small cities; Rural, district area.4 H.S. Park, J.-Y. Park, H.-J. Cho
more positive views on anti-obesity medications, whereas
older physicians and those working in rural areas had more
concerns about the side effects of these agents.
About half of the primary care physicians reported prescrib-
ing anti-obesity medication to patients at their initial visit,
instead of first encouraging these patients to exercise and mo-
dify dietary intake. Approximately 90% of the physicians
reported experiencing a situation where a nonobese patient
asked them to prescribe anti-obesity medications, even though
the patient did not meet the criteria for drug therapy. In these
cases, about 30% of the physicians reported prescribing the
medication immediately upon request and 40% reported
prescribing the medication only after failing to persuade the
patient against the use of medication. In addition, about one-
quarter of these physicians reported prescribing combinations
of anti-obesity medications. Physicians who were younger or
practiced in urban areas tended to overprescribe anti-obesity
medications.
DISCUSSION
Our results indicated that attitude and practices in manag-
ing obesity among primary care physicians in Korea might
be far from the guideline (8-10). Although the prevalence of
a BMI ≥30 kg/m2 is much lower in Korea (2.3%) (12) than
in Western countries (22.3%) (8), the present results indicate
that primary care physicians in Korea tend to over-prescribe
anti-obesity medications without appropriate evaluation or
without allowing enough time for diet and exercise treatment
to take effect in obese patients.
Before anti-obesity medications came to market, primary
care physicians in Korea were less concerned about the man-
agement of obese patients, even those who were severely obese
or who had obesity-related health problems (16). This lack of
interest in obesity management prior to the advent of anti-
obesity medications may have been due to the fact that in
Korea there is no insurance reimbursement for nonpharma-
cologic treatments such as diet and exercise therapy, making
such treatments less of a concern for physicians. 
Following the availability of anti-obesity medications in
Korea in 2001, interest in obesity management increased both
among patients and physicians. Marketing of these agents
led patients to believe that they could control their weight
with a ‘‘magic bullet’’. Moreover, physicians readily prescribed
these medications to their patients because there is insurance
reimbursement for the prescription fee, although not for the
medications themselves.
We found that many primary care physicians in Korea were
unfamiliar with the definitions of obesity and abdominal obe-
sity, with only half being aware of the definition of obesity
according to the Asia-Pacific regional obesity guidelines. In
addition, the physicians surveyed tended to conduct inade-
quate evaluation of obese patients. Although biennial mea-
surements of BMI and waist circumference are recommended
for the evaluation of obesity and abdominal obesity in asymp-
Total
Age (yr)
<40 40-49 ≥50
Region
Urban Middle Rural
Nonpharmacologic management
Diet modification 62.6 71.8 61.8 52.4* 65.5 65.3 42.9*
Exercise therapy 64.2 71.8 63.7 54.8* 66.4 68.2 42.9*
Attitude towards effectiveness and safety of anti-obesity medications
Effective for weight reduction 31.4 39.3 29.5 26.2* 31.8 34.1 21.4*
Cause too many side effects 8.2 4.3 5.6 21.4* 6.3 8.7 14.3*
Too expensive 61.5 65.0 63.7 50.0* 61.9 62.4 57.1
Prescribe anti-obesity medications to obese patients
At initial visit for weight reduction 47.3 50.4 51.8 29.8* 52.5 45.1 33.9*
After 1 month of diet and exercise  15.3 16.2 13.5 19.0 15.7 15.6 12.5
After 3 months of diet and exercise  30.8 27.4 29.5 39.3 26.5 32.4 42.9
Do not prescribe 4.2 3.4 3.2 8.3 3.1 4.6 7.1
Experience requests by non-obese patients to prescribe anti-obesity medications
Yes 90.7 90.6 94.0 81.0* 92.8 92.5 76.8*
No 9.3 9.4 6.0 19.0 7.2 7.5 23.2
Prescribe anti-obesity medications to nonobese patients
Prescribe at their request 29.8 34.0 30.5 20.6* 29.0 31.3 30.9
Prescribe after persuasion 39.0 40.6 40.3 32.4 38.2 39.4 41.9
Do not prescribe 30.7 25.5 28.8 45.6 31.9 29.4 30.2
Prescribe combinations of anti-obesity medications 
Yes 26.5 27.4 29.9 15.5* 25.6 31.2 16.1*
No 73.5 72.6 70.1 84.5 74.4 68.8 83.9
Table 4. Primary care physicians’ attitudes and practices for management of obesity (as percentage of participants)
*p<0.05 by 
2-test for trend. Urban, large cities; Middle, middle and small cities; Rural, district area.tomatic patients (8), only 15% of physicians measured a pa-
tient’s weight and height at the initial visit, and only 5% mea-
sured waist circumference. 
Even in apparently obese and overweight patients, many
physicians did not adequately assess anthropometric measure-
ments, with only about 50% of physicians measuring BMI
and 20% measuring waist circumference in obese patients.
Since obese patients have higher rates of prevalence and mor-
tality from cardiovascular disorders (17-19), evaluation of risk
factors and the patient’s medical history is needed. Our find-
ings indicate that physicians in Korea are not carrying out suf-
ficient evaluation of cardiovascular risk factors in obese patients.
Although about two-thirds of the physicians reported rec-
ommending diet and exercise therapy, this was lower than
the 92% of family physicians in Germany who attached great
importance to nutritional counseling (20). In managing obe-
sity, diet and exercise therapy is usually tried for 3 to 6 months
before initiating medication (1, 8-10). It has been shown that,
in the management of chronic diseases, lifestyle modification
is more effective than pharmacotherapy (21, 22). Although
only about 30% of our subjects regarded pharmacotherapy
as effective and over 60% agreed that these anti-obesity agents
were too expensive, approximately 50% of the physicians in-
dicated that they would prescribe an anti-obesity medication
at a patient’s initial visit if the patient was willing to lose
weight. Most of the surveyed physicians reported seeing over
50 patients per day, indicating that there are severe constraints
on their time. These time constraints may explain why pri-
mary physicians in Korea tend to take the easier and less time-
and labor-intensive route of prescribing a drug rather than
recommending some type of behavioral therapy. Our results
on physicians in Korea differ from those obtained in a study
of primary care physicians in Israel, which found that only
4% of doctors recommended using regular anti-obesity drug
therapy (23).
Approximately 90% of the physicians surveyed in the pre-
sent study reported being asked to prescribe anti-obesity med-
ication by nonobese patients, and 70% of these physicians
actually prescribed the medication. These findings indicate
that there may be a serious risk of abuse of these drugs. In
addition, about one quarter of the physicians did not hesitate
to prescribe a combination of anti-obesity medications, even
though there is no evidence showing that combinations are
more effective than individual agents. The management of
obesity by Korean physicians thus differed considerably from
basic obesity management guidelines (1, 8-10). Obesity ex-
perts in the U.S., where the prevalence of obesity is high, regard
medications as less important than exercise in treating obe-
sity (24).
Physicians who were older or who practiced in rural areas
had less interest in obesity management. In contrast, younger
physicians or those who worked in urban areas tended to over-
prescribe anti-obesity agents. Although family physicians have
been reported to be more aggressive in the treatment of obe-
sity than other physicians in the United Sates (14), we observ-
ed no significant differences in attitudes or reported practice
according to specialty.
Our study had several limitations. The response rate of phy-
sicians was low, although we regard those who participated as
adequate representative subjects selected by systematic random
sampling among family physicians and internists in Korea.
In addition, use of a self-reporting questionnaire may have
led to an overestimation of the rate of physicians’ evaluation
of obesity and/or an underestimation of the rate of physicians’
prescription of anti-obesity medications.
In conclusion, we have found that primary care physicians
in Korea do not sufficiently evaluate obesity in their patients,
yet they over-prescribe anti-obesity medications. Anti-obe-
sity medications are not covered by insurance in Korea, and
thus cost a patient about 83 to 125 US dollars per month.
Over-prescription of anti-obesity medications adds much to
the national cost of medical care (25). Our findings suggest
that primary care physicians in Korea need more education
about obesity and its management, with an emphasis on pru-
dent prescription of anti-obesity agents. This should enhance
the contribution of primary care physicians to the appropri-
ate management of obesity.
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